Overview

Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether a significant and predictable change in bioavailability of extended-release venlafaxine occurs following Roux-en-Y gastric bypass.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Venlafaxine Hydrochloride